Hepatitis B Virus Infection among Health Care Workers in Indonesia

Abstract

Hepatitis B virus (HBV) infection is a global health problem with an estimated 257 million chronically infected people. Indonesia is a moderately hepatitis B-endemic country with 7.1% prevalence of hepatitis surface antigen (HBsAg). This infection is considered as an important occupational hazard among health care workers (HCWs), who may become further transmitters of this infection. The extent of hepatitis B among HCWs and specific control strategy are not available in Indonesia. A study was done on 644 HCWs, who were categorized into administration, nonintervention, and intervention groups. The prevalence of HBsAg, antibody to HBV core antigen (anti-HBc), and antibody to HBsAg (anti-HBs) was 4.7, 18.5, and 36.7% respectively, while 57.3% were negative for all seromarkers, indicating susceptibility to this infection. Increasing trend with age was observed in the exposure to infection (anti-HBc) (p <0.001) and the marker of resolved infection (HBsAg-, anti-HBc+, anti-HBs+) (p = 0.004), suggesting accumulated exposure to HBV infection by increasing age. Rising trend of exposure rate was also observed across the administration, nonintervention, and intervention groups (p < 0.001). By length of service period, significant escalation of exposure (p = 0.010) and resolved infection (p < 0.001) were also observed, suggesting increasing occupational risk to HBV infection. There is an urgent need to safeguard the HCWs with hepatitis B vaccination and provide continuing education at various health care setups. The establishment of a national policy and a roadmap for effective and efficient intervention is required for the prevention, diagnosis, postexposure management, and treatment of HBV infection in this special population.How to cite this article: Muljono DH, Wijayadi T, Sjahril R. Hepatitis B Virus Infection among Health Care Workers in Indonesia. Euroasian J Hepato-Gastroenterol 2018;8(1):88-92.

Hepatitis B Infection and Immunity among Pregnant Women Attending Antenatal Clinics in Health Centers of Mbarara Municipality, Southwestern Uganda

“…Suffice to note that HBV integrates and persists for life in the hepatocyte nuclei as covalently closed circular DNA (cccDNA) [4] thus the virus may reactivate when HBsAb levels reduce [11]; moreover the integrated virus accelerates procarcinogenic events that trigger hepatocyte turnover [3] and may lead to cancer of the liver. Our findings are different from what was observed among Health Care Workers (HCWs) in Indonesia where 18.5% had natural immunity and 36% had artificial immunity [20]. This difference is expected and it would probably be observed in our study had it been done among HCWs in whom HepB vaccination is offered before one starts to interface with patients.…”

Hepatitis B screening and vaccination status of healthcare providers in Wakiso district, Uganda

“…The public health challenge of HBV infections in healthcare settings in many resource-constrained countries is accelerated by limited access to diagnosis and treatment for hepatitis B [ 1 , 10 ]. In addition, a lack of awareness of HBV and precautionary measures to take against blood-borne infections among HCPs has been reported to be a risk factor for infection [ 11 – 13 ]. Yet, if left untreated, chronic HBV carriers develop severe complications including cirrhosis, liver failure and hepatocellular carcinoma [ 1 ].…”

High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study

“…Therefore, the reported prevalence varied considerably among HCPs working in different countries, and even within the same country. More than two decades after successful implementation of the universal infantile HB immunization along with HB vaccination of the highrisk groups and adolescents catch-up immunization program in the world and Iran, the prevalence of HB infection and HBsAg carrier reduced significantly among general population and some high-risk groups including HCP in the many countries and even within the same country in the world [2,36]: 0.3% (0.15-2.7) in USA [37], 0.9% (0.1-4.4%) in EU [38], 1% in India [24], 4.7% in Indonesia [39], and 8.7% (5.2-14.3%) in Cameron [26]. The prevalence of HB infection in Iran reduced in line with its global downward trend [40,41].…”